Article Text

other Versions

PDF
CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer
  1. Lise M A De Strooper1,
  2. Marjolein van Zummeren1,
  3. Renske D M Steenbergen1,
  4. Maaike C G Bleeker1,
  5. Albertus T Hesselink1,
  6. G Bea A Wisman2,
  7. Peter J F Snijders1,
  8. Daniëlle A M Heideman1,
  9. Chris J L M Meijer1
  1. 1Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
  2. 2Department of Gynaecological Oncology, University Medical Centre Groningen, Groningen, The Netherlands
  1. Correspondence to Professor Chris J L M Meijer, Department of Pathology, VU University Medical Center, PO box 7057, Amsterdam 1007 MB, The Netherlands; cjlm.meijer{at}vumc.nl

Abstract

Aims Gene promoter hypermethylation is recognised as an essential early step in carcinogenesis, indicating important application areas for DNA methylation analysis in early cancer detection. The current study was set out to assess the performance of CADM1, MAL and miR124-2 methylation analysis in cervical scrapes for detection of cervical and endometrial cancer.

Methods A series of cervical scrapes of women with cervical (n=79) or endometrial (n=21) cancer, cervical intraepithelial neoplasia grade 3 (CIN3) (n=16) or CIN2 (n=32), and women without evidence of CIN2 or worse (n=120) were assessed for methylation of CADM1, MAL and miR124-2. Methylation analysis was done by the PreCursor-M assay, a multiplex quantitative methylation-specific PCR.

Results All samples of women with cervical cancer (79/79, 100%), independent of the histotype, and 76% (16/21; 95% CI 58.0% to 94.4%) of women with endometrial cancer scored positive for DNA methylation for at least one of the three genes. In women without cancer, methylation frequencies increased significantly with severity of disease from 19.2% (23/120; 95% CI 12.1% to 26.2%) in women without CIN2 or worse to 37.5% (12/32; 95% CI 20.7% to 54.3%) and 68.8% (11/16; 95% CI 46.0% to 91.5%) in women with CIN2 and CIN3, respectively. Overall methylation positivity and the number of methylated genes increased proportionally to the lesion severity.

Conclusions DNA methylation analysis of CADM1, MAL and miR124-2 in cervical scrapes consistently detects cervical cancer and the majority of CIN3 lesions, and has the capacity to broaden its use on cervical scrapes through the detection of a substantial subset of endometrial carcinomas.

  • HPV
  • CERVICAL CANCER
  • diagnostic screening
  • ENDOMETRIUM

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.